Introduction Over 46 million people are living with rheumatic heart disease (RHD) globally, resulting in 380 000 premature ...

Background Although socioeconomic inequalities in infant mortality are well-documented globally, there is limited evidence ...

It is well established that social determinants influence people’s health and well-being. Yet, limited attention is given to ...

Five years after the start of the COVID-19 pandemic, pushback against global health initiatives is common amidst declining ...

Four decades of war and armed conflict have created a complex and prolonged humanitarian crisis in Afghanistan. The country, with a population of approximately 41 million, is grappling with rapid ...

As we mark 5 years since the emergence of the COVID-19 pandemic, the world continues to face numerous epidemics of emerging and re-emerging diseases, including mpox, cholera, avian influenza, ...

Clinical research is sine qua non for understanding and solving public health challenges.1 Clinical trials are central to advancing scientific knowledge and can have an impact on many areas (but not ...

As leaders of medical schools across Africa, we articulate our shared commitment to dynamic, innovative and socially ...

Communicating health risks via social media is an important objective for public health organisations. Behavioural science ...

Introduction Screening to identify traumatic births and childbirth-related post-traumatic stress disorder (CB-PTSD) is ...

Since 2012, the WHO has recommended a single low dose of primaquine (SLDPQ, 0.25 mg/kg) alongside artemisinin-based ...

The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in ...